Celcuity (CELC) Other Non Operating Income (2020 - 2024)
Celcuity (CELC) reported Other Non Operating Income of -$1.0 million for Q4 2024, down 218.73% on a YoY basis from $880800.0 in Q1 2024, and down 490.05% quarter-over-quarter from $268110.0 in Q3 2024.
Celcuity (CELC) Other Non Operating Income (2020 - 2024) Analysis & Trends
Celcuity has reported Other Non Operating Income for 5 years, with the latest figure at -$1.0 million in Q4 2024.
- For the quarter ending Q4 2024, Other Non Operating Income fell 218.73% year-over-year to -$1.0 million; the trailing twelve-month figure through Dec 2024 stood at $665000.0 (down 72.87% YoY), and the FY2025 full-year result was $645000.0, down 3.01% from the prior year.
- Other Non Operating Income for Q4 2024 stood at -$1.0 million, down from $268110.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $881380.0 in Q1 2024, with the low at -$1.0 million in Q4 2024.
- Historically, Other Non Operating Income has averaged $47688.8 across 5 years, with a median of $5777.0 in 2020.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 418572.55% — and 2023, when it jumped 1422.35%.
- Celcuity's Other Non Operating Income stood at $443.0 in 2020, then plunged by 97754.18% to -$432608.0 in 2021, then jumped by 113.37% to $57858.0 in 2022, then jumped by 1422.35% to $880800.0 in 2023, then tumbled by 218.73% to -$1.0 million in 2024.
- The last three Other Non Operating Income figures came in at -$1.0 million (Q4 2024), $268110.0 (Q3 2024), and $561266.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.05 Mn |
| Sep 30, 2024 | 268,110.00 |
| Jun 30, 2024 | 561,266.00 |
| Mar 31, 2024 | 881,380.00 |
| Dec 31, 2023 | 880,800.00 |
| Sep 30, 2023 | 493,497.00 |
| Jun 30, 2023 | 467,798.00 |
| Mar 31, 2023 | 609,120.00 |
| Dec 31, 2022 | 57,858.00 |
| Sep 30, 2022 | -250,166.00 |
| Jun 30, 2022 | -359,799.00 |
| Mar 31, 2022 | -426,842.00 |
| Dec 31, 2021 | -432,608.00 |
| Sep 30, 2021 | -427,460.00 |
| Jun 30, 2021 | -389,384.00 |
| Mar 31, 2021 | 102.00 |
| Dec 31, 2020 | 443.00 |
| Sep 30, 2020 | 5,777.00 |
| Jun 30, 2020 | 11,952.00 |